229 related articles for article (PubMed ID: 16931891)
1. No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.
Oldhoff JM; Darsow U; Werfel T; Bihari IC; Katzer K; Laifaoui J; Plötz S; Kapp A; Knol EF; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
Int Arch Allergy Immunol; 2006; 141(3):290-4. PubMed ID: 16931891
[TBL] [Abstract][Full Text] [Related]
2. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
Oldhoff JM; Darsow U; Werfel T; Katzer K; Wulf A; Laifaoui J; Hijnen DJ; Plötz S; Knol EF; Kapp A; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
Allergy; 2005 May; 60(5):693-6. PubMed ID: 15813818
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%.
Oldhoff JM; Knol EF; Laaper-Ertmann M; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Allergy; 2006 May; 61(5):622-8. PubMed ID: 16629794
[TBL] [Abstract][Full Text] [Related]
4. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
5. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.
Assa'ad AH; Gupta SK; Collins MH; Thomson M; Heath AT; Smith DA; Perschy TL; Jurgensen CH; Ortega HG; Aceves SS
Gastroenterology; 2011 Nov; 141(5):1593-604. PubMed ID: 21835135
[TBL] [Abstract][Full Text] [Related]
6. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM
N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody.
Smith DA; Minthorn EA; Beerahee M
Clin Pharmacokinet; 2011 Apr; 50(4):215-27. PubMed ID: 21348536
[TBL] [Abstract][Full Text] [Related]
8. Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin.
Phipps S; Flood-Page P; Menzies-Gow A; Ong YE; Kay AB
J Invest Dermatol; 2004 Jun; 122(6):1406-12. PubMed ID: 15175031
[TBL] [Abstract][Full Text] [Related]
9. The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema.
Gfesser M; Rakoski J; Ring J
Br J Dermatol; 1996 Oct; 135(4):560-5. PubMed ID: 8915146
[TBL] [Abstract][Full Text] [Related]
10. Atopy patch test in the diagnosis of food allergy in children with atopic eczema dermatitis syndrome.
Cudowska B; Kaczmarski M
Rocz Akad Med Bialymst; 2005; 50():261-7. PubMed ID: 16358980
[TBL] [Abstract][Full Text] [Related]
11. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
12. Elevated peripheral allergen-specific T cell response is crucial for a positive atopy patch test reaction.
Johansson C; Ahlborg N; Andersson A; Lundeberg L; Karlsson MA; Scheynius A; Tengvall Linder M
Int Arch Allergy Immunol; 2009; 150(1):51-8. PubMed ID: 19339802
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.
Flood-Page PT; Menzies-Gow AN; Kay AB; Robinson DS
Am J Respir Crit Care Med; 2003 Jan; 167(2):199-204. PubMed ID: 12406833
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study.
Darsow U; Laifaoui J; Kerschenlohr K; Wollenberg A; Przybilla B; Wüthrich B; Borelli S; Giusti F; Seidenari S; Drzimalla K; Simon D; Disch R; Borelli S; Devillers AC; Oranje AP; De Raeve L; Hachem JP; Dangoisse C; Blondeel A; Song M; Breuer K; Wulf A; Werfel T; Roul S; Taieb A; Bolhaar S; Bruijnzeel-Koomen C; Brönnimann M; Braathen LR; Didierlaurent A; André C; Ring J
Allergy; 2004 Dec; 59(12):1318-25. PubMed ID: 15507101
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of the cutaneous cellular infiltrate after atopy patch testing in cats with atopic dermatitis.
Roosje PJ; Thepen T; Rutten VP; van den Brom WE; Bruijnzeel-Koomen CA; Willemse T
Vet Immunol Immunopathol; 2004 Oct; 101(3-4):143-51. PubMed ID: 15350744
[TBL] [Abstract][Full Text] [Related]
16. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies.
Lipozencić J; Wolf R
Clin Dermatol; 2010; 28(1):38-44. PubMed ID: 20082949
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Rothenberg ME; Klion AD; Roufosse FE; Kahn JE; Weller PF; Simon HU; Schwartz LB; Rosenwasser LJ; Ring J; Griffin EF; Haig AE; Frewer PI; Parkin JM; Gleich GJ;
N Engl J Med; 2008 Mar; 358(12):1215-28. PubMed ID: 18344568
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions.
Langeveld-Wildschut EG; Bruijnzeel PL; Mudde GC; Versluis C; Van Ieperen-Van Dijk AG; Bihari IC; Knol EF; Thepen T; Bruijnzeel-Koomen CA; van Reijsen FC
J Allergy Clin Immunol; 2000 May; 105(5):1008-16. PubMed ID: 10808184
[TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.
Straumann A; Conus S; Grzonka P; Kita H; Kephart G; Bussmann C; Beglinger C; Smith DA; Patel J; Byrne M; Simon HU
Gut; 2010 Jan; 59(1):21-30. PubMed ID: 19828470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
